Amwins

Mitigating Risk Just Got Simpler with Amwins Gene Therapy Solutions (GTS-15) Amwins Gene Therapy Solutions (GTS-15) is an innovative reimbursement program that provides access to 15 FDA-approved cell and gene therapy treatments. Mitigating risk for self-funded employers just got simpler. Find out how at the link below. https://hubs.li/Q02Wn7w_0 #GeneTherapy #StopLoss #EmployeeBenefits #CostContainment

🌐 Cyber risk is on everyone’s radar! 🚨 Join KDIS on November 6th for their latest webinar, Community Association Cyber Concerns Reach All-Time High, featuring Kevin Davis and Sherry Branson. Don’t miss out—sign up today! https://lnkd.in/eZrNr22E #CyberRisk #Webinar #StayInformed

Medical Breakthroughs Shouldn’t Break the Bank. Introducing Amwins Gene Therapy Solutions (GTS-15) Scientific breakthroughs in gene and cell therapies are miraculous. But the costs can be staggering, reaching up to $4.25 million. Amwins Gene Therapy Solutions (GTS-15) is an innovative reimbursement program that provides access to 15 FDA-approved cell and gene therapy treatments. For more information on how Amwins Gene Therapy Solutions (GTS-15) can benefit your self-funded employers visit the link below. https://hubs.li/Q02VGG4Z0 #GeneTherapy #StopLoss #EmployeeBenefits

🔍 Within cyber insurance, brokers face new complexities that demand a deeper understanding of policy nuances. 🛡️ As highlighted in this article from Insurance Business America the shift toward expanded coverage in a competitive market means it's crucial for brokers to examine the fine print closely. Matt Donovan, RPLU, EVP, Amwins Brokerage, emphasizes that while the market is softening, hidden exclusions could significantly impact clients in the event of cyber incidents. With cyber threats on the rise, ensuring robust coverage—especially for dependent business interruptions—has never been more vital. Dive into the details and discover how staying informed can protect your clients from the unexpected! 💡 https://hubs.li/Q02VyRkC0 #CyberInsurance #InsuranceBrokers #RiskManagement

Ready to dive into the ever-changing landscape of cannabis, marine coverage, and security? Our October edition of The Edge has arrived! Check out these essential articles: 🍹 Cannabis Beverage Boom Creates Uncertainty and Opportunity - https://hubs.li/Q02VmvH20 🌊 Marine Coverage: A Deep Dive into Today’s Marketplace - https://hubs.li/Q02VmmTN0 👮 Police Professional Liability: A Necessary Evolution in Security - https://hubs.li/Q02VmlDb0 With expert insights from our team, this edition is packed with valuable content to keep you informed and ahead of the game. Staying in the loop on industry trends is key to your success—make sure you don’t miss it! #TheEdge #IndustryInsights #Cannabis #MarineCoverage #PoliceLiability #WeHelpYouWin

Minimize Risk Not Coverage. Unlock the benefits of Amwins Gene Therapy Solutions (GTS-15) Amwins Group Benefits is helping self-funded employers prioritize employee health without compromising the bottom line with Amwins Gene Therapy Solutions (GTS-15). GTS-15 is an innovative reimbursement program that provides access to 15 FDA-approved cell and gene therapy treatments. For more information on Amwins Group Benefits or GTS-15 visit the link below. https://hubs.li/Q02TPgtz0 #GeneTherapy #StopLoss #EmployeeBenefits #CostContainment

As California's insurance market faces unprecedented challenges, Korbin Holck, Amwins Access, highlights a silver lining: an anticipated influx of capacity over the next year. This means more innovative and tailored solutions for wildfire risks. With the right strategies in place, including advanced risk management tools and customized coverage options, Amwins is ready to navigate this evolving landscape. Check out the full article from Insurance Business America to learn how we're turning challenges into opportunities! https://hubs.li/Q02TJlPS0 #WildfireRisk #CaliforniaMarket #AmwinsAccess

Amwins Rx, part of Amwins Group Benefits, is excited to relaunch the Retiree RxCare website - your go-to resource for the Amwins Rx-administered Medicare Prescription Drug Plan! At Amwins Rx, we are committed to simplifying the Medicare Part D experience. From clear guidance to personalized support, we’re here to help members make informed healthcare decisions with ease. We’ve also enhanced accessibility, providing instant accommodations to ensure all members have a consistent experience, regardless of their needs. With over 20 years of Medicare Part D expertise, Amwins Rx is dedicated to supporting members throughout their healthcare journey. Together, we can make a difference. To discover how we’re enhancing the Medicare Part D experience for everyone, please visit: https://hubs.li/Q02ThYht0 #AmwinsRx #WeHelpYouWin #Medicare

Amwins Group Benefits is excited to introduce Amwins Gene Therapy Solutions (GTS-15)! GTS-15 offers access to 15 FDA-approved cell and gene therapy treatments, providing an innovative reimbursement program for self-funded clients. Click the link below to learn more about Amwins Group Benefits and GTS-15. https://hubs.li/Q02SX-Qm0 #GeneTherapy #StopLoss #EmployeeBenefits

Amwins Underwriting is proud to be a long-time supporter of Target Markets Program Administrators Association (TMPAA) and a Gold Sponsor of their 24th annual summit! Our underwriting leaders can’t wait to connect with you in Arizona in less than two weeks—where program business gets done. See you there! #AmwinsOnTarget #Underwriting #WeHelpYouWin